Clinical trial
Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal…
NCT00184769 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184769 |
|---|---|
| Title | Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. |
| Official title | Open Randomized Trial Examining the Growth and Safety Effects of Treatment With Recombinant Growth Hormone on Infants Aged 1 to 2 Years With Growth Retardation Secondary to Chronic Renal Insufficiency |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Chronic Renal Insufficiency |
| Intervention type | Drug |
| Interventions | somatropin |
| Enrollment | 16 |
| Start date | Jan 29, 1998 |
| Primary completion | Dec 21, 2005 |
| Completion | Dec 21, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 27, 2017 |
| Countries | Portugal, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: